Dr. Kade Goepferd expresses deep concern as the Trump administration takes steps to ban gender-affirming care for transgender youth, igniting backlash from medical professionals and advocates.
A proposed rule by Health Secretary Robert F. Kennedy Jr. could shut down non-compliant hospitals, impacting gender treatment for minors. With nearly half of U.S. hospitals dependent on federal funding, this move raises serious concerns.
In a groundbreaking decision, the FDA has lifted the black box warnings on hormone replacement therapy for menopause, potentially improving access for women seeking relief from menopausal symptoms.
In a groundbreaking move, President Trump announces deals with Eli Lilly and Novo Nordisk to reduce obesity drug prices, making treatments more accessible for millions of Americans. Medicare coverage for GLP-1 drugs starts in 2026, changing the landscape of obesity treatment.
In a heated private call, Marjorie Taylor Greene criticized Speaker Mike Johnson over the GOP's handling of the government shutdown, sparking tensions within the party as consequences of inaction loom large.
In an inspiring announcement, the National Academy of Medicine (NAM) has elected 90 regular members and 10 international members who have made significant contributions to health and medicine. NAM President Victor J. Dzau highlighted the exceptional qualifications of these new members, emphasizing their roles in addressing pressing health challenges and advancing medical research. This new cohort strengthens NAM's mission to inspire positive actions across various sectors.
Frustrated seniors across the nation report being denied COVID-19 vaccinations due to new policies. As cases rise, many are left scrambling for access amid bureaucratic hurdles and healthcare regulations.
The AAP's new recommendations for pediatric COVID-19 vaccines clash with CDC guidance, prompting HHS Secretary Kennedy to issue a warning about potential liability for physicians. Experts respond.
Eli Lilly announces a dramatic price increase for its diabetes medication Mounjaro in the UK, raising the monthly cost from £122 to £330. This change affects private buyers but not NHS prescriptions. Learn more about the implications!
In a shocking twist, Senator Josh Hawley proposes repealing Medicaid cuts he supported just weeks prior. This move has sparked widespread mockery and highlights the complexities within the GOP as they navigate Trump's influence.